Prosecution Insights
Last updated: October 02, 2026
Application No. 18/710,199

PROCESS FOR PREPARING ISOCYANATOORGANOSILANES

Non-Final OA §103
Filed
May 15, 2024
Priority
Jan 31, 2022 — nonprovisional of PCTEP2022052242
Examiner
WITHERSPOON, SIKARL A
Art Unit
Tech Center
Assignee
Wacker Chemie AG
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
66%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
1432 granted / 1661 resolved
+26.2% vs TC avg
Minimal -20% lift
Without
With
+-20.1%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 9m
Avg Prosecution
38 currently pending
Career history
1674
Total Applications
across all art units

Statute-Specific Performance

§101
3.4%
-36.6% vs TC avg
§103
46.2%
+6.2% vs TC avg
§102
17.1%
-22.9% vs TC avg
§112
17.3%
-22.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1661 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 11-19 is/are rejected under 35 U.S.C. 103 as being unpatentable over Kreczinski et al. (US 10,611,782) in view of Stanjek et al. (US 8,158,818). The claims are drawn to a method for preparing isocyantoalkylalkoxysilanes PNG media_image1.png 622 654 media_image1.png Greyscale PNG media_image2.png 216 638 media_image2.png Greyscale Kreczinski et al. teaches a process for preparing isocyanates containing alkoxysilane groups by a series of steps comprising, (a) reacting a haloalkylalkoxysilane with a metal cyanate and an alcohol to form an alkoxysilanoalkylurethane; (b) freeing the alkoxysilanoalkyl urethane from low/high boilers, solids, and salts, followed by distillation, e.g., by thin film evaporation; (c) thermally cleaving the alkoxysilanoalkylurethane to form the isocyanatoalkylalkoxysilane, and then (d), separating the target compound and by-products and from bottoms material and collected (abstract). Step (a) may be conducted in the presence of an aprotic solvent, e.g., dimethylformamide, dimethylsulfoxide, dimethyl carbonate, and mixtures thereof. Distillation of alkoxysilanoalkylurethane in step (b) may be conducted at pressures from 20-800 mar, preferably from 40-600 mbar, and temperatures from 40-200°C, most preferably from 40-180°C (col. 3, line 65 to col. 6, line 55; examples). The process steps may be conducted continuously, such that bottom material containing alcohol may be fed back to a previous step. The difference between Kreczinski et al. and the present invention is that the reference does not expressly teach that step (b) is conducted in an evaporator wherein the silane is vaporized in a layer thickness of not more than 5 cm; however, Stanjek et al. teach a process for preparing isocyanatoorganosilanes, wherein a thin film evaporator is used to evaporate the carbamate-functional silane (i.e., the alkoxysilanoalkylurethane taught by Kreczinski et al.) having a thickness not exceeding 5cm is used (col, 2, lines 38-49). The instant claims are therefore rendered obvious in view of the combined reference teachings, since Stanjek et al. teaches the same vaporization step as recited by Kreczinski et al. and teaches parameters of the thin film vaporizer that may be used in both references, and renders the instant claims obvious. Claim 20 is objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SIKARL A WITHERSPOON whose telephone number is (571)272-0649. The examiner can normally be reached M-F 9am-9pm IFP. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SIKARL A WITHERSPOON/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

May 15, 2024
Application Filed
Sep 15, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741027
USE OF HIGH MOLECULAR WEIGHT HYALURONIC ACID AS OCULAR TRANSPORTING VEHICLE
3y 9m to grant Granted Sep 22, 2026
Patent 12735377
SPIN ON METAL-ORGANIC FORMULATIONS
2y 11m to grant Granted Sep 15, 2026
Patent 12735374
PREPARATION METHOD OF TRANS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE
2y 8m to grant Granted Sep 15, 2026
Patent 12728083
1,3-BUTYLENE GLYCOL PRODUCT
4y 6m to grant Granted Sep 08, 2026
Patent 12729214
METHOD OF PRODUCING ALKENYL PHOSPHORUS COMPOUND
3y 2m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
66%
With Interview (-20.1%)
1y 9m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1661 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month